TB/HIV comorbidity has declined since 1993, but more work remains to be done.
During the late 1980s and early 1990s, the number of tuberculosis (TB) cases in the U.S. increased by 20% after declining for more than 30 years. Several factors were responsible for this resurgence of TB, but the emerging HIV epidemic was probably the most important. In 1993, the federal government began allocating additional resources for TB control, and, in 1996, potent antiretroviral therapy became widely available. Consequently, the incidence of both TB and AIDS began to decline steadily. In the present study, investigators evaluated trends in TB/HIV comorbidity, using nationwide data from all incident cases of TB that were reported to the CDC from 1993 through 2004.
The annual number of new TB cases declined from 42,536 in 1993 to 20,6…
Reviewing Author
DisclosuresGrant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; NIH/National Institute on Drug Abuse
Editorial BoardsJAIDS: Journal of Acquired Immune Deficiency Syndromes; Vaccines
Leadership Positions in Professional SocietiesInternational Antiviral Society–USA (Board of Directors); Infectious Diseases Society of America (Past President)
DisclosuresGrant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; NIH/National Institute on Drug Abuse
Editorial BoardsJAIDS: Journal of Acquired Immune Deficiency Syndromes; Vaccines
Leadership Positions in Professional SocietiesInternational Antiviral Society–USA (Board of Directors); Infectious Diseases Society of America (Past President)